I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Leyssen, Maarten
90
results:
Search for persons
X
Format
Online (90)
Mediatypes
Articles (Online) (28)
OpenAccess-fulltext (62)
Sorted by: Relevance
Sorted by: Year
?
1
Protocol for a phase 3 trial to evaluate the effectiveness ..:
Watson-Jones, Deborah
;
Kavunga-Membo, Hugo
;
Grais, Rebecca F
...
BMJ Open. 12 (2022) 3 - p. e055596 , 2022
Link:
https://doi.org/10.1136/..
?
2
Non-human primate to human immunobridging demonstrates a pr..:
Bockstal, Viki
;
Leyssen, Maarten
;
Heerwegh, Dirk
...
npj Vaccines. 7 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
3
Safety, reactogenicity, and immunogenicity of a 2-dose Ebol..:
Karita, Etienne
;
Nyombayire, Julien
;
Ingabire, Rosine
...
Trials. 23 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
4
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV..:
Anywaine, Zacchaeus
;
Barry, Houreratou
;
Anzala, Omu
...
PLOS Medicine. 19 (2022) 1 - p. e1003865 , 2022
Link:
https://doi.org/10.1371/..
?
5
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV..:
Barry, Houreratou
;
Mutua, Gaudensia
;
Kibuuka, Hannah
...
PLOS Medicine. 18 (2021) 10 - p. e1003813 , 2021
Link:
https://doi.org/10.1371/..
?
6
Assessments of different batches and dose levels of a two-d..:
Bockstal, Viki
;
Gaddah, Auguste
;
Goldstein, Neil
...
npj Vaccines. 6 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1038/..
?
7
Vaccines based on replication incompetent Ad26 viral vector..:
Custers, Jerome
;
Kim, Denny
;
Leyssen, Maarten
...
Vaccine. 39 (2021) 22 - p. 3081-3101 , 2021
Link:
https://doi.org/10.1016/..
?
8
Nonhuman primate to human immunobridging to infer the prote..:
Roozendaal, Ramon
;
Hendriks, Jenny
;
van Effelterre, Thierry
...
npj Vaccines. 5 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1038/..
?
9
Lot-to-lot consistency, safety and immunogenicity of 3 lots..:
Klein, Nicola P.
;
Abu-Elyazeed, Remon
;
Cornish, Matthew
...
Vaccine. 35 (2017) 28 - p. 3564-3574 , 2017
Link:
https://doi.org/10.1016/..
?
10
A Randomized, Controlled, Observer-Blinded Phase 1 Study of..:
Langley, Joanne M.
;
Aggarwal, Naresh
;
Toma, Azhar
...
The Journal of Infectious Diseases. 215 (2017) 1 - p. 24-33 , 2017
Link:
http://www.jstor.org/sta..
?
11
A Randomized, Controlled, Observer-Blinded Phase 1 Study of..:
Langley, Joanne M.
;
Aggarwal, Naresh
;
Toma, Azhar
...
Journal of Infectious Diseases. 215 (2016) 1 - p. 24-33 , 2016
Link:
https://doi.org/10.1093/..
?
12
Immunity to hepatitis A and B persists for at least 15 year..:
Beran, Jiri
;
Van Der Meeren, Olivier
;
Leyssen, Maarten
.
Vaccine. 34 (2016) 24 - p. 2686-2691 , 2016
Link:
https://doi.org/10.1016/..
?
13
Mutations in the Intellectual Disability Gene Ube2a Cause N..:
Haddad, Dominik M.
;
Vilain, Sven
;
Vos, Melissa
...
Molecular Cell. 50 (2013) 6 - p. 831-843 , 2013
Link:
https://doi.org/10.1016/..
?
14
Immunogenicity and safety of an investigational AS02v-adjuv..:
Tielemans, Christian L.
;
Vlasak, Jiri
;
Kosa, Dezider
...
Vaccine. 29 (2011) 6 - p. 1159-1166 , 2011
Link:
https://doi.org/10.1016/..
?
15
Antibody Persistence and Immune Memory 4 Years Post‐Vaccina..:
Chlibek, Roman
;
von Sonnenburg, Frank
;
Van Damme, Pierre
...
Journal of Travel Medicine. 18 (2011) 2 - p. 145-148 , 2011
Link:
https://doi.org/10.1111/..
1-15